BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By | 2016-03-03T14:33:54+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By | 2016-03-03T14:36:01+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:30:24+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:31:04+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Announces Closing of Public Offering of Common Stock HANGZHOU, China--(BUSINESS WIRE)--April 28, 2010--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJDD) ("Jo-Jo Drugstores" or the "Company"), which operates a retail pharmacy chain in the People’s Republic of China (the “PRC”), today announced that it closed its previously announced public offering of 3.5 million shares of common stock. Gross proceeds to]

By | 2016-03-11T07:33:39+00:00 April 28th, 2010|Categories: Chinese Stocks, CJJD, SEC Original|Tags: , , , , , |0 Comments
Read More

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores, Inc. Announces Closing of Public

[China Jo-Jo Drugstores, Inc. Announces Closing of Public Offering of Common Stock HANGZHOU, China--(BUSINESS WIRE)--April 28, 2010--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJDD) ("Jo-Jo Drugstores" or the "Company"), which operates a retail pharmacy chain in the People’s Republic of China (the “PRC”), today announced that it closed its previously announced public offering of 3.5 million shares of common stock. Gross proceeds to]

By | 2016-03-11T07:34:29+00:00 April 28th, 2010|Categories: Chinese Stocks, CJJD, Webplus ver|Tags: , , , , , |0 Comments
Read More

CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Enters Agreement to Acquire Four Radiotherapy and Diagnostic Imaging Acquisition to Strengthen Company’s Presence in Northern China BEIJING, CHINA, April 27, 2010 — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its wholly-owned subsidiary, Shenzhen Aohua Medical Device] [FORM 6-K CONCORD MEDICAL SERVICES 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes N/A 82- TABLE OF CONTENTS TABLE OF CONTENTS — Press release regarding the acquisition of four radiotherapy and diagnostic imaging centers in Hebei province 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K]

By | 2016-03-13T12:11:24+00:00 April 28th, 2010|Categories: CCM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CCM [Concord Medical Services] 6-K: Concord Medical Enters Agreement to Acquire Four Radiotherapy

[Concord Medical Enters Agreement to Acquire Four Radiotherapy and Diagnostic Imaging Acquisition to Strengthen Company’s Presence in Northern China BEIJING, CHINA, April 27, 2010 — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its wholly-owned subsidiary, Shenzhen Aohua Medical Device] [FORM 6-K CONCORD MEDICAL SERVICES 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes N/A 82- TABLE OF CONTENTS TABLE OF CONTENTS — Press release regarding the acquisition of four radiotherapy and diagnostic imaging centers in Hebei province 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K]

By | 2016-03-13T12:12:44+00:00 April 28th, 2010|Categories: CCM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

GSI [GENERAL STEEL] DEFA14A: NOT APPLICABLE Payment of Filing Fee (Check the

[NOT APPLICABLE Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies:]

By | 2016-03-14T18:21:09+00:00 April 28th, 2010|Categories: Chinese Stocks, GSI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar